Cargando…
Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring?
BACKGROUND: Suppressive doses of levothyroxine therapy are reported to reduce bone mineral density (BMD) in women. Data on bone changes in premenopausal hypothyroid women with replacement therapy are limited. Hence, this study was undertaken to evaluate bone changes in this group using bone markers...
Autores principales: | Babu, Ruby P, Christy, Alap, Hegde, Anupama, Manjrekar, Poornima, D’Souza, Vivian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362625/ https://www.ncbi.nlm.nih.gov/pubmed/25861238 http://dx.doi.org/10.4137/CMWH.S22114 |
Ejemplares similares
-
Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss
por: Christy, Alap L., et al.
Publicado: (2014) -
Levothyroxine Replacement Improves Oxidative Status in Primary Hypothyroidism
por: Masullo, Laís Farias, et al.
Publicado: (2018) -
Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism
por: Shakir, Mohamed K M, et al.
Publicado: (2021) -
Adherence to Levothyroxine Tablet in Patients with Hypothyroidism
por: Kumar, Rohan, et al.
Publicado: (2019) -
Levothyroxine Therapy in Elderly Patients With Hypothyroidism
por: Effraimidis, Grigoris, et al.
Publicado: (2021)